Last reviewed 2026-04-19 · How we verify

Oximen® 3%

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · Phase 1 active Small molecule

At a glance

Generic name	Oximen® 3%
Also known as	H2O2, Hydrogen peroxide
Sponsor	Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Oximen® 3% CI brief — competitive landscape report
Oximen® 3% updates RSS · CI watch RSS
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana portfolio CI